ATE301996T1 - Behandlung von narbengewebe mit liponsäure - Google Patents

Behandlung von narbengewebe mit liponsäure

Info

Publication number
ATE301996T1
ATE301996T1 AT98958031T AT98958031T ATE301996T1 AT E301996 T1 ATE301996 T1 AT E301996T1 AT 98958031 T AT98958031 T AT 98958031T AT 98958031 T AT98958031 T AT 98958031T AT E301996 T1 ATE301996 T1 AT E301996T1
Authority
AT
Austria
Prior art keywords
acid
lipoic
scar tissue
dihydrolipoic
liponic acid
Prior art date
Application number
AT98958031T
Other languages
English (en)
Inventor
Nicholas V Dr Perricone
Original Assignee
Nicholas V Dr Perricone
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nicholas V Dr Perricone filed Critical Nicholas V Dr Perricone
Application granted granted Critical
Publication of ATE301996T1 publication Critical patent/ATE301996T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4986—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with sulfur as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Birds (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
AT98958031T 1997-11-17 1998-11-16 Behandlung von narbengewebe mit liponsäure ATE301996T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/971,820 US5965618A (en) 1997-11-17 1997-11-17 Treatment of scar tissue using lipoic acid
PCT/US1998/024514 WO1999025330A1 (en) 1997-11-17 1998-11-16 Treatment of scar tissue using lipoic acid

Publications (1)

Publication Number Publication Date
ATE301996T1 true ATE301996T1 (de) 2005-09-15

Family

ID=25518838

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98958031T ATE301996T1 (de) 1997-11-17 1998-11-16 Behandlung von narbengewebe mit liponsäure

Country Status (8)

Country Link
US (1) US5965618A (de)
EP (1) EP1039891B1 (de)
JP (1) JP4027593B2 (de)
AT (1) ATE301996T1 (de)
CA (1) CA2309717C (de)
DE (1) DE69831269T2 (de)
ES (1) ES2247728T3 (de)
WO (1) WO1999025330A1 (de)

Families Citing this family (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19701264A1 (de) * 1997-01-16 1998-07-23 Kief Lizenz Verwertungsgesells Heilmittel, enthaltend Betasitosterin und/oder Phytosterol/Betasitosteringemische
US6365623B1 (en) 1997-11-17 2002-04-02 Nicholas V. Perricone Treatment of acne using lipoic acid
FR2793681B1 (fr) * 1999-05-18 2001-06-22 Oreal Utilisation d'au moins un inhibiteur d'au moins un canal calcique dans le traitement des rides
US6288106B1 (en) * 1999-05-25 2001-09-11 Chronorx, Llc Processes for the synthesis and use of various α-lipoic acid complexes
US6572878B1 (en) * 2000-09-07 2003-06-03 Robert Blaine Method and device for treating scars
US7285284B2 (en) * 2000-09-08 2007-10-23 Kuhnau Stephen C Cosmetic composition, method of use and method of making
IT1319195B1 (it) * 2000-10-10 2003-09-26 Laboratorio Chimico Int Spa Processo per la produzione dell'acido r(+)alfa-lipoico.
US6743433B2 (en) 2001-07-06 2004-06-01 Nicholas V. Perricone Treatment of acne using alkanolamine compositions
US6908941B2 (en) * 2002-06-06 2005-06-21 Nicholas V. Perricone Hair and nail treatments using alkanolamines
US6793193B2 (en) * 2002-08-20 2004-09-21 Dart Industries Inc. Adjustable mold for forming shaped food
US7306810B1 (en) 2002-11-25 2007-12-11 Piedmont Cosmeceuticals, Inc. Skin cream
US20040265345A1 (en) * 2003-06-30 2004-12-30 Perricone Nicholas V. Treatment of skin damage using acetyl carnitine and lipoic acid
JP2005104920A (ja) * 2003-09-30 2005-04-21 Ya Man Ltd 皮膚外用剤及びその使用方法
US20050192229A1 (en) * 2004-02-27 2005-09-01 Perricone Nicholas V. Topical glutathione treatments
GB0426255D0 (en) * 2004-11-30 2004-12-29 Younger Skin Ltd Improvements in and relating to products for skin treatment
ITPD20050168A1 (it) * 2005-06-01 2006-12-02 Fidia Advanced Biopolymers Srl Formulazioni di acido lipoico ed acido ialuronico e o suoi derivati e loro impiego in campo farmaceutico e cosmetico
US20070225354A1 (en) * 2006-03-21 2007-09-27 Eric Marchewitz Use of dihydrolipoamide for enhancing physical performance
JP2011507860A (ja) * 2007-12-21 2011-03-10 コーダ セラピューティクス， インコーポレイテッド 異常瘢痕または過剰瘢痕の治療のための抗コネキシンポリヌクレオチドおよび抗コネキシンペプチドの使用
EP2252690A2 (de) * 2007-12-21 2010-11-24 Coda Therapeutics, Inc. Verwendung von anti-connexin-43-polynukleotiden zur behandlung abnormaler oder übermässiger narben
AU2009308152B2 (en) * 2008-10-21 2015-05-21 The General Hospital Corporation Cell transplantation
US9199102B2 (en) 2009-07-21 2015-12-01 Oradin Pharmaceutical Ltd. A3 adenosine receptor ligands for modulation of pigmentation
WO2011152832A1 (en) 2010-06-04 2011-12-08 N.V. Perricone Llc Methods of use of nitroalkene compositions in dermatologic applications to prevent or treat skin aging
WO2012006107A2 (en) 2010-06-28 2012-01-12 Stemtide, Inc. Skin care compositions
JP6072684B2 (ja) 2010-08-06 2017-02-01 ザ ジェネラル ホスピタル コーポレーション ディー／ビー／エイ マサチューセッツ ジェネラル ホスピタル 細胞処置システムおよび細胞処置装置
EP2446905B1 (de) 2010-10-29 2019-10-02 Aesculap AG Medizinische Vorrichtung mit Antikratzmerkmalen
US9034926B2 (en) 2010-12-30 2015-05-19 Nicholas V. Perricone Topical nitrone spin trap compositions for psoriasis
US9421234B2 (en) 2011-05-20 2016-08-23 Nutramax Laboratories, Inc. Orally administrable compositions comprising avocado/soybean unsaponifiables and lipoic acid and methods of administration
US20140328952A1 (en) 2011-12-21 2014-11-06 Dana FLAVIN Topical compositions
WO2013185024A1 (en) * 2012-06-08 2013-12-12 The Ohio State University Treating burn and scar injury using tocotrienol
CN107789660A (zh) * 2016-08-31 2018-03-13 杜建 一种用于皮肤及软组织损伤的医用敷料
PY1917053A (es) * 2018-03-09 2019-09-13 Ocusoft Inc Composiciones tópicas para el cuidado de la piel

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
PT95826B (pt) * 1989-11-09 1997-11-28 Asta Medica Ag Processo para a preparacao de composicoes farmaceuticas contendo como ingrediente activo acido r-alfa-liponico ou acido s-alfa-liponico
US5232702A (en) * 1991-07-22 1993-08-03 Dow Corning Corporation Silicone pressure sensitive adhesive compositons for transdermal drug delivery devices and related medical devices
DE4313428A1 (de) * 1992-01-18 1994-10-27 Margarethe Rabien Kombinationspatent in dem alpha-Liponsäure + Pantothensäure (bzw. Dexpanthenol) vorkommen gegen Entzündungen, Hautkrankheiten entzündlicher + allergischer Natur, schlecht heilende Wunden
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
US5376361A (en) * 1993-01-13 1994-12-27 Perricone; Nicholas V. Method and compositions for topical application to the skin for prevention and/or treatment of radiation-induced skin damage
DE4345199C2 (de) * 1993-05-22 1995-10-12 Asta Medica Ag Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
DE4343593C2 (de) * 1993-12-21 1998-05-20 Asta Medica Ag Verwendung von R-(+)-alpha-Liponsäure, R-(-)-Dihydroliponsäure oder der Metabolite sowie deren Salze, Ester, Amide zur Behandlung kompensierter und dekompensierter Insulinresistenz
US5444091A (en) * 1994-05-24 1995-08-22 Dermatology Home Products, Inc. Method of applying alpha hydroxy acids for treating striae distensae
CN1152865A (zh) * 1994-06-15 1997-06-25 普罗克特和甘保尔公司 对哺乳动物皮肤中色素过度沉着区域的增白方法
US5472698A (en) * 1994-12-20 1995-12-05 Elizabeth Arden Co., Division Of Conopco, Inc. Composition for enhancing lipid production in skin
US5847003A (en) * 1996-06-04 1998-12-08 Avon Products, Inc. Oxa acids and related compounds for treating skin conditions
WO1998036773A1 (en) * 1997-02-20 1998-08-27 Yale University Therapeutic uses for antioxidants

Also Published As

Publication number Publication date
JP4027593B2 (ja) 2007-12-26
JP2001522878A (ja) 2001-11-20
EP1039891A1 (de) 2000-10-04
ES2247728T3 (es) 2006-03-01
EP1039891A4 (de) 2003-06-11
HK1030155A1 (en) 2001-04-27
CA2309717C (en) 2004-01-06
US5965618A (en) 1999-10-12
WO1999025330A1 (en) 1999-05-27
DE69831269T2 (de) 2006-03-30
EP1039891B1 (de) 2005-08-17
CA2309717A1 (en) 1999-05-27
DE69831269D1 (de) 2005-09-22

Similar Documents

Publication Publication Date Title
DE69831269D1 (de) Behandlung von narbengewebe mit liponsäure
KR910001912B1 (ko) 프롤린, 히드록시프롤린 또는 콜라겐의 가수분해 생성물인 아미노산 혼합물의 유도체들을 함유한 화장품 조성물
DE69128653D1 (de) Verwendung von Alphatocopherol phosphate oder eines Derivates davon zur Herstellung kosmetischer, dermatologischer oder pharmazeutischer Präparate mit anti-radikaler Aktivität und Zusammensetzungen
KR950031034A (ko) 화장품 또는 피부과용 조성물 및 그의 제법
ATE91407T1 (de) Verwendung von salicylsaeure-derivaten zur behandlung des hautalterns.
CA2232583A1 (en) Lipoic acid in topical compositions
ATE181502T1 (de) Potenzierung von antimikrobiellen wirkungen
ES2131700T3 (es) Composicion cosmetica que contiene hidroxiacidos.
DE60034458D1 (de) Pflaster zur äusserlichen anwendung
EP0336880A3 (de) Verwendung von topisch applizierbaren Präparaten zur Behandlung der Altershaut
ATE536170T1 (de) Verwendung von kationischen tensiden in kosmetischen mitteln
DE68913476D1 (de) Kosmetisches Präparat.
MXPA01006455A (es) Composiciones para el cuidado de la piel que contienen acido linoleico cis-9, trnas-11.
PT774962E (pt) Utilizacao de dha como uma composicao farmaceutica
WO2001026606A2 (en) Treatment of scar tissue using lipoic acid
ATE406154T1 (de) Zusammensetzung enthaltend ozonisierte öle und/oder andere natürliche und/oder synthetische ozonizierte produkte und ihre verwendung in pharmazeutischen, kosmetischen, diätetischen oder nahrungsergänzenden zusammensetzungen in human- und veterinärgebieten
BR9815418A (pt) Composição farmacêutica ou cosmética tópica, composição farmacêutica, alimentar ou cosmética e utilização de pelo menos um dos agnim
ATE268587T1 (de) Gebrauch von silicongummi zur stabilisierung von ascorbinsaüre und vorbereitungen die diese zusammensetzungen enthalten
JPS56120611A (en) Beautifying cosmetic
CA2495870A1 (en) Compositions and methods for treating skin conditions
AU2929692A (en) Dermatological and cosmetic compositions
MD940026A (ro) Compoziţie, folosită în calitate de supliment la materialul vegetal
RU2004119850A (ru) Композиция на основе сложного диосгенина для топического нанесения
ATE204741T1 (de) Dimere säuren in kosmetika und arzneimitteln
DE69629282D1 (de) Verwendung eines pyruvatdehydrogenaseaktivators zur behandlung der ischämie in gliedern

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties